Our Recent Pricing Whitepapers

More White Papers

Trust the process of high pharma prices to incentivize innovation and competition

There have been some record-breaking prices set for drugs in recent months. Such high prices for pharmaceuticals are on the minds of many of the payers and clinicians that I speak with during pricing research projects. Such high prices should encourage innovation and competition, and once a specific unmet need has been addressed, the price of treating that specific medical problem will likely come down over time. Continue reading…

The Changing Chinese Consumer: “Doing it their way”

A recent article by The Economist described China as the “next consumption superpower”. On the verge of becoming the second largest consumer economy in the world, it has become a uniquely attractive market for many reasons. However, the evolving Chinese consumer also represents a challenge for international companies. Continue reading…

The Presentation of Pricing Information: Package Price

Price Ending in High-Low Context Countries

Framing Online Promotions

Why Canadians will be more active in paying for healthcare

Price Endings in Risky Product Categories

When Supply and Demand Meet: Structural Models of Pricing

New product adoption speed and its impact on the launch pricing strategy

Canadian Healthcare Payers (White Paper, 2011)

Price Point Endings

Price Endings in Asia

Interested in more resources?